Critical juncture for key brands
Frida Wang | Ryan Wong
CLV releases its FY20 result > ST uncertainty does not change the future growth pipeline
Frida Wang | Ryan Wong
Head of China Research
Unpacking the Fed’s thought process > What this means for Value
Tony Brinker
Institutional Equity Research
BGA FY20 result analysis > Can COVID keep a good food company down
Mark Topy | Ryan Wong
Institutional Research
BKL releases its FY20 result > Business turnaround is on the way
Frida Wang | Ryan Wong
Head of China Research
US housing rates versus bond rates > A story of Value?
Tony Brinker
Institutional Equity Research
A2 releases its FY20 result > Channel shift uncertainty remains into 1Q21
Frida Wang | Ryan Wong
Head of China Research
COVID-19 disruption not avoided > focus on stabilising the growth curve
Mark Topy | Ryan Wong
Institutional Research
What is the real return > Preview of the upcoming FY20 result, and review of the company’s submissions to the Parliamentary Inquiry
Peter Meichelboeck
Head of Research
Select Equities takes a detailed look at the company’s turnaround strategy > Could the healthy food trend be the right recipe for growth?
Mark Topy | Ryan Wong
Institutional Research
Detailed review of Dr LeWinn’s strategy and growth potential > Can Dr LeWinn’s keep this up?
Frida Wang | Ryan Wong
Head of China Research
